Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McMaster University
Original Assignee
McMaster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2012/000175external-prioritypatent/WO2012116432A1/fr
Application filed by McMaster UniversityfiledCriticalMcMaster University
Priority to CA2865826ApriorityCriticalpatent/CA2865826A1/fr
Publication of CA2865826A1publicationCriticalpatent/CA2865826A1/fr
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
CA2865826A2012-02-282013-02-28Dosages de detection pour identifier et valider des agents qui ciblent des cellules souches cancereuses
AbandonedCA2865826A1
(fr)
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence
Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells